These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 31081015)

  • 1. Neuropathological correlates of structural and functional imaging biomarkers in 4-repeat tauopathies.
    Spina S; Brown JA; Deng J; Gardner RC; Nana AL; Hwang JL; Gaus SE; Huang EJ; Kramer JH; Rosen HJ; Kornak J; Neuhaus J; Miller BL; Grinberg LT; Boxer AL; Seeley WW
    Brain; 2019 Jul; 142(7):2068-2081. PubMed ID: 31081015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcortical tau is linked to hypoperfusion in connected cortical regions in 4-repeat tauopathies.
    Roemer SN; Brendel M; Gnörich J; Malpetti M; Zaganjori M; Quattrone A; Gross M; Steward A; Dewenter A; Wagner F; Dehsarvi A; Ferschmann C; Wall S; Palleis C; Rauchmann BS; Katzdobler S; Jäck A; Stockbauer A; Fietzek UM; Bernhardt AM; Weidinger E; Zwergal A; Stöcklein S; Perneczky R; Barthel H; Sabri O; Levin J; Höglinger GU; Franzmeier N
    Brain; 2024 Jul; 147(7):2428-2439. PubMed ID: 38842726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome: a distinct clinicopathologic subtype.
    Koga S; Kouri N; Walton RL; Ebbert MTW; Josephs KA; Litvan I; Graff-Radford N; Ahlskog JE; Uitti RJ; van Gerpen JA; Boeve BF; Parks A; Ross OA; Dickson DW
    Acta Neuropathol; 2018 Sep; 136(3):389-404. PubMed ID: 29926172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion tensor magnetic resonance imaging for single subject diagnosis in neurodegenerative diseases.
    Sajjadi SA; Acosta-Cabronero J; Patterson K; Diaz-de-Grenu LZ; Williams GB; Nestor PJ
    Brain; 2013 Jul; 136(Pt 7):2253-61. PubMed ID: 23729473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies.
    Irwin DJ; Cohen TJ; Grossman M; Arnold SE; Xie SX; Lee VM; Trojanowski JQ
    Brain; 2012 Mar; 135(Pt 3):807-18. PubMed ID: 22366796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular pathology and synaptic loss in primary tauopathies: an 18F-AV-1451 and 11C-UCB-J PET study.
    Holland N; Malpetti M; Rittman T; Mak EE; Passamonti L; Kaalund SS; Hezemans FH; Jones PS; Savulich G; Hong YT; Fryer TD; Aigbirhio FI; O'Brien JT; Rowe JB
    Brain; 2022 Mar; 145(1):340-348. PubMed ID: 34398211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does corticobasal degeneration exist? A clinicopathological re-evaluation.
    Ling H; O'Sullivan SS; Holton JL; Revesz T; Massey LA; Williams DR; Paviour DC; Lees AJ
    Brain; 2010 Jul; 133(Pt 7):2045-57. PubMed ID: 20584946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
    Riku Y; Iwasaki Y; Ishigaki S; Akagi A; Hasegawa M; Nishioka K; Li Y; Riku M; Ikeuchi T; Fujioka Y; Miyahara H; Sone J; Hattori N; Yoshida M; Katsuno M; Sobue G
    Brain; 2022 Aug; 145(8):2769-2784. PubMed ID: 35274674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration.
    Briel N; Pratsch K; Roeber S; Arzberger T; Herms J
    Brain Pathol; 2021 Jul; 31(4):e12914. PubMed ID: 33089580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau deposition patterns are associated with functional connectivity in primary tauopathies.
    Franzmeier N; Brendel M; Beyer L; Slemann L; Kovacs GG; Arzberger T; Kurz C; Respondek G; Lukic MJ; Biel D; Rubinski A; Frontzkowski L; Hummel S; Müller A; Finze A; Palleis C; Joseph E; Weidinger E; Katzdobler S; Song M; Biechele G; Kern M; Scheifele M; Rauchmann BS; Perneczky R; Rullman M; Patt M; Schildan A; Barthel H; Sabri O; Rumpf JJ; Schroeter ML; Classen J; Villemagne V; Seibyl J; Stephens AW; Lee EB; Coughlin DG; Giese A; Grossman M; McMillan CT; Gelpi E; Molina-Porcel L; Compta Y; van Swieten JC; Laat LD; Troakes C; Al-Sarraj S; Robinson JL; Xie SX; Irwin DJ; Roeber S; Herms J; Simons M; Bartenstein P; Lee VM; Trojanowski JQ; Levin J; Höglinger G; Ewers M
    Nat Commun; 2022 Mar; 13(1):1362. PubMed ID: 35292638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular processing of aggregated tau differs between corticobasal degeneration and progressive supranuclear palsy.
    Arai T; Ikeda K; Akiyama H; Tsuchiya K; Yagishita S; Takamatsu J
    Neuroreport; 2001 Apr; 12(5):935-8. PubMed ID: 11303763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau burden and the functional connectome in Alzheimer's disease and progressive supranuclear palsy.
    Cope TE; Rittman T; Borchert RJ; Jones PS; Vatansever D; Allinson K; Passamonti L; Vazquez Rodriguez P; Bevan-Jones WR; O'Brien JT; Rowe JB
    Brain; 2018 Feb; 141(2):550-567. PubMed ID: 29293892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gradient subthalamic neurodegeneration and tau pathology in the hypoglossal nucleus as essential pathological markers of progressive supranuclear palsy - Richardson syndrome.
    Homma T; Mochizuki Y; Hara M; Kamei S; Mizutani T; Takubo H; Isozaki E; Takahashi M; Komori T; Hao H
    Rev Neurol (Paris); 2020 May; 176(5):353-360. PubMed ID: 32247606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau protein quantification in skin biopsies differentiates tauopathies from alpha-synucleinopathies.
    Vacchi E; Lazzarini E; Pinton S; Chiaro G; Disanto G; Marchi F; Robert T; Staedler C; Galati S; Gobbi C; Barile L; Kaelin-Lang A; Melli G
    Brain; 2022 Aug; 145(8):2755-2768. PubMed ID: 35485527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key emerging issues in progressive supranuclear palsy and corticobasal degeneration.
    Josephs KA
    J Neurol; 2015 Mar; 262(3):783-8. PubMed ID: 25701010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histologic lesion type correlates of magnetic resonance imaging biomarkers in four-repeat tauopathies.
    Carlos AF; Tosakulwong N; Weigand SD; Buciuc M; Ali F; Clark HM; Botha H; Utianski RL; Machulda MM; Schwarz CG; Reid RI; Senjem ML; Jack CR; Ahlskog JE; Dickson DW; Josephs KA; Whitwell JL
    Brain Commun; 2022; 4(3):fcac108. PubMed ID: 35663380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of [
    Tezuka T; Takahata K; Seki M; Tabuchi H; Momota Y; Shiraiwa M; Suzuki N; Morimoto A; Nakahara T; Iwabuchi Y; Miura E; Yamamoto Y; Sano Y; Funaki K; Yamagata B; Ueda R; Yoshizaki T; Mashima K; Shibata M; Oyama M; Okada K; Kubota M; Okita H; Takao M; Jinzaki M; Nakahara J; Mimura M; Ito D
    Brain Commun; 2021; 3(4):fcab190. PubMed ID: 34632382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy.
    Boxer AL; Geschwind MD; Belfor N; Gorno-Tempini ML; Schauer GF; Miller BL; Weiner MW; Rosen HJ
    Arch Neurol; 2006 Jan; 63(1):81-6. PubMed ID: 16401739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the movement disorder society criteria for the diagnosis of 4-repeat tauopathies.
    Respondek G; Grimm MJ; Piot I; Arzberger T; Compta Y; Englund E; Ferguson LW; Gelpi E; Roeber S; Giese A; Grossman M; Irwin DJ; Meissner WG; Nilsson C; Pantelyat A; Rajput A; van Swieten JC; Troakes C; Höglinger GU;
    Mov Disord; 2020 Jan; 35(1):171-176. PubMed ID: 31571273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome: a cortical variant.
    Ling H; de Silva R; Massey LA; Courtney R; Hondhamuni G; Bajaj N; Lowe J; Holton JL; Lees A; Revesz T
    Neuropathol Appl Neurobiol; 2014 Feb; 40(2):149-63. PubMed ID: 23432126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.